Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 1
1970 1
1971 1
1974 1
1978 2
1980 7
1981 3
1983 3
1984 2
1985 4
1986 5
1987 5
1988 5
1989 6
1990 9
1991 18
1992 8
1993 23
1994 23
1995 22
1996 23
1997 27
1998 31
1999 54
2000 62
2001 61
2002 99
2003 108
2004 137
2005 133
2006 184
2007 201
2008 266
2009 293
2010 311
2011 378
2012 460
2013 478
2014 521
2015 600
2016 587
2017 655
2018 764
2019 879
2020 948
2021 1160
2022 1271
2023 357
Text availability
Article attribute
Article type
Publication date

Search Results

9,928 results
Results by year
Filters applied: . Clear all
Page 1
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, Hughes BGM, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Kaufman HL, Seebach F, Lowy I, Yoo SY, Mathias M, Fenech K, Han H, Fury MG, Rischin D. Gross ND, et al. Among authors: han h. N Engl J Med. 2022 Oct 27;387(17):1557-1568. doi: 10.1056/NEJMoa2209813. Epub 2022 Sep 12. N Engl J Med. 2022. PMID: 36094839 Clinical Trial.
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
Yang P, Song L, Zhang Y, Zhang X, Chen X, Li Y, Sun L, Wan Y, Billot L, Li Q, Ren X, Shen H, Zhang L, Li Z, Xing P, Zhang Y, Zhang P, Hua W, Shen F, Zhou Y, Tian B, Chen W, Han H, Zhang L, Xu C, Li T, Peng Y, Yue X, Chen S, Wen C, Wan S, Yin C, Wei M, Shu H, Nan G, Liu S, Liu W, Cai Y, Sui Y, Chen M, Zhou Y, Zuo Q, Dai D, Zhao R, Li Q, Huang Q, Xu Y, Deng B, Wu T, Lu J, Wang X, Parsons MW, Butcher K, Campbell B, Robinson TG, Goyal M, Dippel D, Roos Y, Majoie C, Wang L, Wang Y, Liu J, Anderson CS; ENCHANTED2/MT Investigators. Yang P, et al. Among authors: han h. Lancet. 2022 Nov 5;400(10363):1585-1596. doi: 10.1016/S0140-6736(22)01882-7. Epub 2022 Oct 28. Lancet. 2022. PMID: 36341753 Clinical Trial.
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
Pan Y, Han H, Hu H, Wang H, Song Y, Hao Y, Tong X, Patel AS, Misirlioglu S, Tang S, Huang HY, Geng K, Chen T, Karatza A, Sherman F, Labbe KE, Yang F, Chafitz A, Peng C, Guo C, Moreira AL, Velcheti V, Lau SCM, Sui P, Chen H, Diehl JA, Rustgi AK, Bass AJ, Poirier JT, Zhang X, Ji H, Zhang H, Wong KK. Pan Y, et al. Among authors: han h. Cancer Cell. 2023 Jan 9;41(1):88-105.e8. doi: 10.1016/j.ccell.2022.11.015. Epub 2022 Dec 15. Cancer Cell. 2023. PMID: 36525973
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.
Huo X, Ma G, Tong X, Zhang X, Pan Y, Nguyen TN, Yuan G, Han H, Chen W, Wei M, Zhang J, Zhou Z, Yao X, Wang G, Song W, Cai X, Nan G, Li D, Wang AY, Ling W, Cai C, Wen C, Wang E, Zhang L, Jiang C, Liu Y, Liao G, Chen X, Li T, Liu S, Li J, Gao F, Ma N, Mo D, Song L, Sun X, Li X, Deng Y, Luo G, Lv M, He H, Liu A, Zhang J, Mu S, Liu L, Jing J, Nie X, Ding Z, Du W, Zhao X, Yang P, Liu L, Wang Y, Liebeskind DS, Pereira VM, Ren Z, Wang Y, Miao Z; ANGEL-ASPECT Investigators. Huo X, et al. Among authors: han h. N Engl J Med. 2023 Feb 10. doi: 10.1056/NEJMoa2213379. Online ahead of print. N Engl J Med. 2023. PMID: 36762852
Interventions to reduce partisan animosity.
Hartman R, Blakey W, Womick J, Bail C, Finkel EJ, Han H, Sarrouf J, Schroeder J, Sheeran P, Van Bavel JJ, Willer R, Gray K. Hartman R, et al. Among authors: han h. Nat Hum Behav. 2022 Sep;6(9):1194-1205. doi: 10.1038/s41562-022-01442-3. Epub 2022 Sep 19. Nat Hum Behav. 2022. PMID: 36123534 Review.
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer.
Niu N, Qiu F, Xu Q, He G, Gu X, Guo W, Zhang D, Li Z, Zhao Y, Li Y, Li K, Zhang H, Zhang P, Huang Y, Zhang G, Han H, Cai Z, Li P, Xu H, Chen G, Xue J, Jiang X, Jahromi AH, Li J, Zhao Y, de Faria Castro Fleury E, Huo S, Li H, Jerusalem G, Tripodi D, Liu T, Zheng X, Liu C. Niu N, et al. Among authors: han h. Nat Commun. 2022 Nov 17;13(1):7043. doi: 10.1038/s41467-022-34838-w. Nat Commun. 2022. PMID: 36396665 Free PMC article. Clinical Trial.
Mitophagy in ototoxicity.
Han H, Hu S, Hu Y, Liu D, Zhou J, Liu X, Ma X, Dong Y. Han H, et al. Front Cell Neurosci. 2023 Feb 23;17:1140916. doi: 10.3389/fncel.2023.1140916. eCollection 2023. Front Cell Neurosci. 2023. PMID: 36909283 Free PMC article. Review.
Fatty Exosomes Aggravate Metabolic Disorders.
Jung YH, Han HJ. Jung YH, et al. Among authors: han hj. Mol Cells. 2022 Oct 31;45(10):692-694. doi: 10.14348/molcells.2022.0135. Epub 2022 Oct 6. Mol Cells. 2022. PMID: 36254711 Free PMC article. No abstract available.
9,928 results